WAM
COLL icon

Wolverine Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Wolverine Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,864
Closed -$538K – 1643
2025
Q1 		$563K Buy
+18,864
New +$576K 0.01% 826
2023
Q2 		– Sell
-3
Closed -$68 – 1830
2023
Q1 		$71 Buy
+3
New +$80 ﹤0.01% 1827
2022
Q4 		– Sell
-25
Closed – – 2151
2022
Q3 		$0 Buy
+25
New +$441 ﹤0.01% 2400

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wolverine Asset Management's COLL Position: Q2 2025 in Review

Wolverine Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 18,864 shares — an estimated $538K sold.

Wolverine Asset Management first reported a position in COLL in Q3 2022 and held it in 3 quarters. The position peaked at $563K in Q1 2025. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

  • Wolverine Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 18,864 Collegium Pharmaceutical shares in Q2 2025, an estimated $538K.
  • Wolverine Asset Management first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 3 quarters.
  • Wolverine Asset Management's Collegium Pharmaceutical position peaked at $563K in Q1 2025.
  • 223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on Wolverine Asset Management's 13F filing for Q2 2025, filed 4 Aug 2025.